Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine the immunogenicity and efficacy of HBsAg Vaccine in combination with Entecavir in patients who have been treated with HB110E HBV DNA vaccine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genexine, Inc.
NCT06092333 · Chronic Hepatitis B
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT02932150 · Chronic Hepatitis B
NCT07343778 · Chronic Hepatitis B With Hepatic Fibrosis
NCT06671093 · Chronic Hep B, Chronic Hepatitis b, and more
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions